Single-receptor, dual-receptor, and triple-receptor agonists represent an escalating spectrum of metabolic intervention, and the dosing complexity increases proportionally with each additional receptor target
Retrieved March 19, 2022
Coverage varies significantly: Check Your Regional Formulary Look up Zepbound on Kaiser's official formulary tools: California Alert: 2025 Coverage Changes Effective January 1, 2025, Kaiser California implemented major restrictions for GLP-1 weight loss drugs
Prescription medications are final sale
Is Weight Loss With Semaglutide Sustainable
Start your intake Sourcing Pathways: Branded, Compounded, and Telehealth Options GLP-1 agonists are accessible through three primary routes: brand-name medications (Ozempic, Wegovy, Mounjaro, Zepbound) dispensed by traditional retail or mail-order pharmacies